Cyberounds Logo
July 29, 2010 | LOGIN | REGISTER | HELP | 


email a friend print Bookmark and Share
Chemical Warfare Agents
CME credit is no longer available for this conference.
Robert Snyder, Ph.D., Fellow A.T.S., and Paul J. Lioy, Ph.D.

Dr. Snyder is Director, Environmental and Occupational Health Sciences Institute, Professor and Chairman, Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey. Dr. Lioy is Associate Director, Environmental and Occupational Health Sciences Institute, and Professor, Department of Environmental and Community Medicine, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School.

During the past three years, Dr. Snyder has received grant/research support from the American Petroleum Institute and Dr. Lioy has received grant/research support from IBM, SC Johnson and the American Petroleum Institute.


Release Date: 02/06/2002
Termination Date: 02/06/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, the participant should be able to:
  • List the most common nerve agents and vesicants
  • Identify the acute toxic effects of nerve agents and vesicants
  • Describe treatment of acute exposure to nerve agents and vesicants.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity